RxDoctor Payments Data

Nikolas Kaloudis, PA

Medical · New Port Richey, FLNPI 1760992051

Payments from drug & device makers

$1,999in general payments, 2019–2025

Across 70 payments — averaging $28.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$557
  • Pfizer$462
  • E.r. Squibb & Sons, L.L.C.$191
  • AstraZeneca$182
  • Novartis$179
  • Medtronic$178
  • plus $250 from 6 others

What the payments were for

  • Food & beverage$1,999100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,999 in reported general payments places this provider in the 70th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$47,775
Medicare patients
326
Services billed
604

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban331$371,902
XareltoRivaroxaban94$80,390
EntrestoSacubitril/Valsartan58$70,655
BrilintaTicagrelor35$27,181
JardianceEmpagliflozin15$19,786
FarxigaDapagliflozin Propanediol11$11,094
Metoprolol Succinate331$4,747
Diltiazem 24hr Er (Cd)Diltiazem Hcl50$2,152
Atorvastatin Calcium255$2,149
Ranolazine ErRanolazine32$1,854
Isosorbide Mononitrate ErIsosorbide Mononitrate116$1,611
Rosuvastatin Calcium114$1,594
Losartan Potassium125$1,097
Amlodipine Besylate198$1,059
Midodrine Hcl12$936

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$462$371,902331 claims
NovartisEntresto$179$70,65558 claims
AstraZenecaBrilinta, Farxiga$182$38,27546 claims
Boehringer IngelheimJardiance$79$19,78615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,031 medical providers in Florida.

Other medical in New Port Richey

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →